We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Polar Capital Healthcare Opportunities Class I - Income (USD)

Sell:$77.42 Buy:$77.42 Change: $0.47 (0.61%)
Prices as at 21 November 2024
Sell:$77.42
Buy:$77.42
Change: $0.47 (0.61%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 21 November 2024
Sell:$77.42
Buy:$77.42
Change: $0.47 (0.61%)
Prices as at 21 November 2024
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Asset Allocation

X-ray asset allocation
Key % Net Assets
International Equities 98.44%
UK Equities 2.34%
Cash and Equiv. -0.78%

Top 10 holdings

Stock name % Weight Country Sector
1 SWEDISH ORPHAN BIOVITRUM AB (PUBL) 9.77% Sweden Pharmaceuticals & Biotechnology
2 ZEALAND PHARMA A/S 7.79% Denmark Pharmaceuticals & Biotechnology
3 NOVO NORDISK A/S 6.46% Denmark Pharmaceuticals & Biotechnology
4 UCB S.A. 5.82% Belgium Pharmaceuticals & Biotechnology
5 SANOFI 4.49% France Pharmaceuticals & Biotechnology
6 ARGENX SE 4.31% Netherlands Pharmaceuticals & Biotechnology
7 FRESENIUS SE & CO. KGAA 4.23% Germany Health Care Providers
8 INTUITIVE SURGICAL 3.73% United States Medical Equipment & Services
9 SANDOZ GROUP AG 3.35% Switzerland Pharmaceuticals & Biotechnology
10 MAX INDIA LTD 3.07% India Health Care Providers

Where is the fund invested?

UK
Equities
Int'l
Equities
UK
Bonds
Int'l
Bonds
UK
Gilts
Managed Funds Property Other Cash and Equiv. Total
Consumer Staples 2.24% 2.24%
Health Care 2.34% 94.06% 96.41%
Industrials 2.14% 2.14%
Cash and Equiv. -0.78% -0.78%
Total 2.34% 98.44% -0.78% 100.00%
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Data as at 30 September 2024. Data provided by Broadridge.

Fund Analysis is only available on the desktop version of our website. This can be accessed using a desktop or laptop PC or some larger tablets.

You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account